Abstract:Abstract Background Acute fatty liver of pregnancy (AFLP) is an acute, rare and potentially lethal disease typically occurring in the third trimester of pregnancy. So far, there is no effective means of prevention. Therefore, in this study, we retrospectively analyzed the clinical features of AFLP patients for a better understanding. Meanwhile, for the first time, the genetic background associated with the onset of AFLP was discussed by high-throughput sequencing, hoping to provide evidence for genetic counseling and prenatal diagnosis of AFLP. Methods Thirteen AFLP patients admitted to our hospital and other hospital from March 2012 to February 2020 were selected. Clinical data about general condition, laboratory test, liver biopsy and the prognosis of mother and fetus were collected for retrospective analysis. In addition, the peripheral blood of five patients with AFLP and one newborn infant of his mother with AFLP was sequenced with whole-exome sequencing and gene mutation was analyzed by bioinformatics methods. Results The initial symptoms of AFLP varied differently, with jaundice (9/13, 69%), fatigue (8/13, 62%) and nausea and vomiting (6/13, 46%) being the most common. Moreover, the main maternal complications were coagulopathy (13/13, 100%), followed by acute renal dysfunction (10/13, 77%). Raised serum bilirubin, transaminases and uric acid were found in all patients (100%), hypoglycemia was found in six patients (46%) and fatty liver on ultrasound was seen in five patients (5/12, 42%). One (7%) maternal death occurred and all neonates survived delivery. In addition, to our surprise, whole-exome sequencing showed that no gene mutation in related enzymes involved in fatty acid metabolism was noted in the pregnant women and children receiving genetic testing. Conclusions Early visit, early detection, early termination of pregnancy and multidisciplinary comprehensive treatment are the key factors to improve the prognosis of AFLP patients and their newborn infants. Furthermore, although limited size of study, to our knowledge, this report is the first to present the lack of common mutation involved in fatty acid oxidation in Chinese patients with AFLP via whole-exome sequencing. Thus, further studies are needed with larger and more varied samples to validate the conclusion.

Fetal Genotypes and Pregnancy Outcomes in 35 Families with Mitochondrial Trifunctional Protein Mutations

Prospective Screening for Pediatric Mitochondrial Trifunctional Protein Defects in Pregnancies Complicated by Liver Disease

A fetus with mitochondrial trifunctional protein deficiency: Elevation of 3-OH-acylcarnitines in amniotic fluid functionally assured the genetic diagnosis

Obesity is Potentially Associated with a Novel Mitochondrial Trnagly 10029A>G Mutation in a Chinese Family

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations

No Mutation Was Found in the Alpha-Subunit of the Mitochondrial Tri-Functional Protein in One Patient with Severe Acute Fatty Liver of Pregnancy and Her Relatives

Screening for G1528C Mutation in Mitochondrial Trifunctional Protein Gene in Pregnant Women with Severe Preeclampsia and New Born Infant

Fetal and obstetrics manifestations of mitochondrial diseases

Identification and Functional Characterization of Mutations Within HADHB Associated with Mitochondrial Trifunctional Protein Deficiency.

Prenatal Diagnosis of Mitochondrial Disease: Analysis of 28 Pedigrees with Mitochondrial DNA Mutation

Twin-twin Transfusion Syndrome is Associated with Alterations in the Metabolic Profile of Maternal Plasma in Early Gestation: a Pilot Study.

Liver Disease in Pregnancy and Fetal Fatty Acid Oxidation Defects

PRENATAL GENETIC DIAGNOSTICS FOR FAMILIES WITH MITOCHONDRIAL DNA DISEASE.

Unique prenatal manifestations of biallelic NDUFAF5 variants: expansion of phenotype

Liver Disease in Pregnancy and Fetal Fatty Acid Oxidation Defects.

Analysis of clinical characteristics and genetic testing in patients with acute fatty liver of pregnancy: a retrospective study

Maternal folate, one-carbon metabolism and pregnancy outcomes

Pregnancy outcome with maternal HNF1B gene mutations and 17q12 deletions

Maternally Inherited Essential Hypertension May Be Associated with the Mutations in Mitochondrial tRNAGlu Gene

Different Effects of Maternal Homocysteine Concentration, MTHFR and MTRR Genetic Polymorphisms on the Occurrence of Fetal Aneuploidy